Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
UBS
Teva
Baxter
US Army
Accenture
McKinsey
Moodys
Daiichi Sankyo

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,500,814

« Back to Dashboard

Which drugs does patent 6,500,814 protect, and when does it expire?

Patent 6,500,814 protects LYBREL and is included in one NDA.

This patent has ten patent family members in eight countries.
Summary for Patent: 6,500,814
Title: Hormonal contraceptive
Abstract:The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a process for the combined, continuous administration of the product of the invention.
Inventor(s): Hesch; Rolf-Dieter (Constance, DE)
Assignee: Wyeth Pharmaceuticals (St. Davids, PA)
Application Number:09/508,648
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,500,814

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Wyeth Pharms Inc LYBREL ethinyl estradiol; levonorgestrel TABLET;ORAL 021864-001 May 22, 2007 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial PREVENTION OF PREGNANCY ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,500,814

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany197 39 916Sep 11, 1997
PCT Information
PCT FiledSeptember 03, 1998PCT Application Number:PCT/DE98/02636
PCT Publication Date:March 18, 1999PCT Publication Number: WO99/12531

International Patents Family Members for US Patent 6,500,814

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 9912531 ➤ Try a Free Trial
Portugal 1011682 ➤ Try a Free Trial
Spain 2200384 ➤ Try a Free Trial
European Patent Office 1935423 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Queensland Health
McKesson
Teva
Cerilliant
Chubb
Dow
Merck
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.